mission
Computable Drug Discovery
Developing the algorithms to automate drug discovery.
- 16 years of experience in computational chemistry
- Strong record of scientific publications in top-tier journals
- Algorithms to cover all the key steps in the pipeline
- Pioneers in molecular dynamics and machine learning
- Winners of the D3R Grand Challenge 4
- Top 30 AI Drug Discovery company in the world
Finding new binding poses for Pfizer with Molecular Dynamics
Partners
We have collaborated with:
- Biogen and Janssen on lead optimization.
- Novartis, predicting off-target effects.
- Pfizer, identifying a binding mode that explained their SAR.
- UCB, simulating a GPCR from inactive state to active state.
News
Recent Posts
CrypticScout is one of the most popular applications of PlayMolecule, Acellera’s drug discovery platform. This mixed solvent MD application allows […]
This new collaboration between C4X Discovery (“C4XD”) and Acellera aims to elucidate the binding mode of a library of new […]
Today we announce the start of the formal collaboration between Acellera and Chemotargets. Both companies have a long history of […]
Newsletter